New Releases from NCBI BookshelfBelzutifan for treating tumours associated with von Hippel-Lindau disease.Belzutifan for treating tumours associated with von Hippel-Lindau disease.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfQuizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia.Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia.
Post Content
Uncategorized
New Releases from NCBI BookshelfNursing Management and Professional Concepts [Internet]. 2nd edition.Nursing Management and Professional Concepts [Internet]. 2nd edition.
This is the second edition of the Nursing Management & Professional Concepts nursing OER textbook that was developed specifically for
Uncategorized
New Releases from NCBI BookshelfAspartame, methyleugenol, and isoeugenol.Aspartame, methyleugenol, and isoeugenol.
This volume of the IARC Monographs provides evaluations of the carcinogenicity of three agents: aspartame, methyleugenol, and isoeugenol.
Uncategorized
New Releases from NCBI BookshelfNational Institute for Health and Care Excellence: Technology Appraisals [Internet].National Institute for Health and Care Excellence: Technology Appraisals [Internet].
NICE Technology Appraisals are recommendations on the use of new and existing medicines and other treatments within the NHS. They
Uncategorized
New Releases from NCBI BookshelfClindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Indication: For the topical treatment of acne vulgaris in patients 12 years of age and older: Reimbursement Recommendation [Internet].Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo): Indication: For the topical treatment of acne vulgaris in patients 12 years of age and older: Reimbursement Recommendation [Internet].
It is recommended that Cabtreo be reimbursed by public drug plans for the topical treatment of acne vulgaris in patients
